These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26864212)

  • 1. Unveiling the "Three-Finger Pharmacophore" Required for p53-MDM2 Inhibition by Saturation-Transfer Difference (STD) NMR Initial Growth-Rates Approach.
    Angulo J; Goffin SA; Gandhi D; Searcey M; Howell LA
    Chemistry; 2016 Apr; 22(17):5858-62. PubMed ID: 26864212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
    Angulo J; Enríquez-Navas PM; Nieto PM
    Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Shin JS; Ha JH; Chi SW
    Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
    Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
    J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-ligand structure determination with the NMR molecular replacement tool, NMR
    Orts J; Riek R
    J Biomol NMR; 2020 Nov; 74(10-11):633-642. PubMed ID: 32621003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR structure of a complex between MDM2 and a small molecule inhibitor.
    Fry DC; Emerson SD; Palme S; Vu BT; Liu CM; Podlaski F
    J Biomol NMR; 2004 Oct; 30(2):163-73. PubMed ID: 15557803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics Simulations.
    Hu G; Xu S; Wang J
    Chem Biol Drug Des; 2015 Dec; 86(6):1351-9. PubMed ID: 26032728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturation transfer difference NMR spectroscopy as a technique to investigate protein-carbohydrate interactions in solution.
    Haselhorst T; Lamerz AC; Itzstein Mv
    Methods Mol Biol; 2009; 534():375-86. PubMed ID: 19277538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
    Rothweiler U; Czarna A; Krajewski M; Ciombor J; Kalinski C; Khazak V; Ross G; Skobeleva N; Weber L; Holak TA
    ChemMedChem; 2008 Jul; 3(7):1118-28. PubMed ID: 18428185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR screening for lead compounds using tryptophan-mutated proteins.
    Rothweiler U; Czarna A; Weber L; Popowicz GM; Brongel K; Kowalska K; Orth M; Stemmann O; Holak TA
    J Med Chem; 2008 Aug; 51(16):5035-42. PubMed ID: 18680271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of MDM2 and MDMX: a structural perspective.
    Riedinger C; McDonnell JM
    Future Med Chem; 2009 Sep; 1(6):1075-94. PubMed ID: 21425995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potency.
    Hardcastle IR; Liu J; Valeur E; Watson A; Ahmed SU; Blackburn TJ; Bennaceur K; Clegg W; Drummond C; Endicott JA; Golding BT; Griffin RJ; Gruber J; Haggerty K; Harrington RW; Hutton C; Kemp S; Lu X; McDonnell JM; Newell DR; Noble ME; Payne SL; Revill CH; Riedinger C; Xu Q; Lunec J
    J Med Chem; 2011 Mar; 54(5):1233-43. PubMed ID: 21314128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of E3-substrate (MDM2-p53)-binding inhibitors: structural aspects.
    Fry DC; Graves B; Vassilev LT
    Methods Enzymol; 2005; 399():622-33. PubMed ID: 16338385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping Approach.
    Zaytsev A; Dodd B; Magnani M; Ghiron C; Golding BT; Griffin RJ; Liu J; Lu X; Micco I; Newell DR; Padova A; Robertson G; Lunec J; Hardcastle IR
    Chem Biol Drug Des; 2015 Aug; 86(2):180-9. PubMed ID: 25388787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interaction.
    Dezi C; Carotti A; Magnani M; Baroni M; Padova A; Cruciani G; Macchiarulo A; Pellicciari R
    J Chem Inf Model; 2010 Aug; 50(8):1451-65. PubMed ID: 20726601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors.
    Xue X; Wei JL; Xu LL; Xi MY; Xu XL; Liu F; Guo XK; Wang L; Zhang XJ; Zhang MY; Lu MC; Sun HP; You QD
    J Chem Inf Model; 2013 Oct; 53(10):2715-29. PubMed ID: 24050442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Orientation Based Fragment Selection in STD NMR Screening.
    Cala O; Krimm I
    J Med Chem; 2015 Nov; 58(21):8739-42. PubMed ID: 26492576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins by in silico approaches and binding assay.
    Golestanian S; Sharifi A; Popowicz GM; Azizian H; Foroumadi A; Szwagierczak A; Holak TA; Amanlou M
    Life Sci; 2016 Jan; 145():240-6. PubMed ID: 26746660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro.
    Krajewski M; Ozdowy P; D'Silva L; Rothweiler U; Holak TA
    Nat Med; 2005 Nov; 11(11):1135-6; author reply 1136-7. PubMed ID: 16270059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.